Financial Partners Group (Tennessee)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.82M | Buy |
26,308
+8,002
| +44% | +$552K | 0.66% | 37 |
|
|
2025
Q1 | $1.27M | Buy |
18,306
+3,922
| +27% | +$272K | 0.55% | 47 |
|
|
2024
Q4 | $1.24M | Buy |
14,384
+3,438
| +31% | +$296K | 0.51% | 52 |
|
|
2024
Q3 | $1.3M | Buy |
10,946
+25
| +0.2% | +$2.98K | 0.49% | 51 |
|
|
2024
Q2 | $1.56M | Buy |
10,921
+3,334
| +44% | +$476K | 0.61% | 40 |
|
|
2024
Q1 | $974K | Sell |
7,587
-1,044
| -12% | -$134K | 0.38% | 60 |
|
|
2023
Q4 | $893K | Buy |
8,631
+37
| +0.4% | +$3.83K | 0.4% | 54 |
|
|
2023
Q3 | $782K | Buy |
+8,594
| New | +$782K | 0.38% | 52 |
|